TxO Austin Midtown is a clinical research site located in Austin, Texas, United States 78705.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
TxO Austin Midtown has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Austin
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
TxO Austin Midtown has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
TxO Austin Midtown has 1 clinical trials on record, with 1 currently active. Their work covers Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
TxO Austin Midtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.